25 Stocks Moving in Friday’s Pre-Market Session

Winners

  • iSpecimen Inc. (NASDAQ: ISPC) rose 56.9% to $16.00 in pre-market trading. The company recently announced that it has been contracted to support new cutting-edge research into COVID-19 seeking insights on its transferability, variants, outcomes and test validity across multiple segments of the population.
  • Allied Healthcare Products, Inc. (NASDAQ: AHPI) was up 29.6% to $6.98 in pre-market trading. Covid-related stocks rose after reports of a new, highly mutated strain, which was feared to be more contagious than the Delta variant.
  • Valneva SE (NASDAQ: VALN) rose 18.1% to $58.93 in pre-market trading. Valneva recently signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate VLA2001 over two years.
  • BIMI International Medical Inc. (NASDAQ: BIMI) rose 16.9% to $0.8210 in pre-market trading. BIMI recently priced its private placement for $7.8 million in proceeds.
  • Alpha Pro Tech, Ltd (NYSE: APT) shares rose 15.2% to $5.90 in pre-market trading. Covid-related stocks rose after reports of a new, highly mutated strain, which was feared to be more contagious than the Delta variant.
  • Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 11.4% to $13.31 in pre-market trading. Aptevo Therapeutics recently announced a clinical update to its Phase 1b extension study evaluating APVO436 in the treatment of AML. Preliminary data observed so far include one complete remission.
  • Ocugen, Inc. (NASDAQ: OCGN) rose 10.9% to $7.87 in pre-market trading. Covid-related stocks rose after reports of a new, highly mutated strain, which was feared to be more contagious than the Delta variant.
  • Nautilus, Inc. (NYSE: NLS) rose 9.9% to $7.81 in pre-market trading.
  • Co-Diagnostics, Inc (NASDAQ: CODX) rose 9.7% to $9.30 in pre-market trading.
  • iBio, Inc. (NYSE: IBIO) rose 9.7% to $0.73 in pre-market trading.
  • GeoVax Labs, Inc. (NASDAQ: GOVX) rose 9.5% to $4.25 in pre-market trading. GeoVax recently highlighted the presentation of COVID-19 vaccine data at the Vaccine World Asia Congress.
  • Zoom Video Communications, Inc. (NASDAQ:ZM) shares rose 9.4% to $227.88 in pre-market trading amid concerns over a new COVID variant found in South Africa, lifting remote working and virtual communications stocks.
  • Beyond Spring Inc. (NASDAQ: BYSI) rose 9.1% to $14.49 in pre-market trading after gaining 5% on Wednesday.

Find out what’s going on in the current market and ask Benzinga’s PreMarket Prep all your questions.

Check out these big penny stock gains and losers

losers

  • Selecta Biosciences, Inc. (NASDAQ:SELB) fell 15.1% to $2.70 in pre-market trading after the company announced that the FDA has granted a clinical discontinuation of the Phase 1/2 clinical trial of SEL-302 due to CMC- related questions.
  • Oncolytics Biotech Inc. (NASDAQ:ONCY) fell 14.9% to $1.60 in pre-market trading. Oncolytics Biotech will present an update of the Phase 2 triple-negative breast cancer trial at the 2021 San Antonio Breast Cancer Symposium on December 9.
  • RAVE Restaurant Group, Inc. (NASDAQ: RAVE) shares fell 14.4% to $1.31 in pre-market trading after gaining 5% on Wednesday.
  • Callon Petroleum Company (NYSE: CPE) fell 12.2% to $54.18 in pre-market trading after jumping about 6% on Wednesday.
  • BIOLASE, Inc. (NASDAQ: BIOL) fell 12.1% to $0.4130 in pre-market trading. Biolase shares gained 12% on Wednesday after the company announced that Nasdaq had granted its request for a 180-day extension to meet Nasdaq’s minimum bid price requirement again.
  • Mechel PAO (NYSE: MTL) shares fell 11.1% to $2.87 in pre-market trading. Mechel recently reported a turnover in the third quarter of 102.9 billion rubles.
  • Carnival Corporation & plc (NYSE: CUK) fell 11% to $16.54 in pre-market trading after a new COVID variant was discovered in South Africa, clouding travel prospects.
  • Canoe Inc. (NASDAQ: GOEV) shares fell 11% to $11.02 in pre-market trading after rising 7% on Wednesday.
  • Reliance Global Group, Inc. (NASDAQ: RELI) shares fell 10% to $2.33 in pre-market trading after gaining 7% on Wednesday.
  • Royal Caribbean Cruises Ltd. (NYSE: RCL) fell 9.8% to $70.55 in pre-market trading after a new COVID variant was discovered in South Africa, clouding travel prospects.
  • Gracell Biotechnology Inc. (NASDAQ: GRCL) fell 8.2% to $6.51 in pre-market trading. Gracell Biotechnologies recently reported that members of the senior management team plan to use personal funds to purchase up to $2 million worth of business advertising on the open market over the next 3 months.
  • NOV Inc. (NYSE: NOV) shares fell 7.4% to $11.91 in pre-market trading. NOV last week said it has reinstated its regular quarterly dividend of $0.05 per share.

Leave a Comment